Genetic testing can help determine your treatment options for Fabry

There are several laboratory testing options to diagnose Fabry disease. A blood test can determine alpha-Gal A enzyme activity. However, the level of enzyme activity measured while you are untreated does not determine your treatment options. A genetic test is more precise and may help determine your treatment options.

Oral therapy may be an option for adults with a GLA gene variant that is amenable (responsive) to Galafold. Your healthcare provider can help you identify if your GLA variant is amenable.

Galafold® (migalastat)
An oral option for adults with confirmed Fabry disease and an amenable GLA gene variant.

Enzyme replacement therapy (ERT)
Administered intravenously (IV) for patients with Fabry disease.

Galafold is designed to work with your own alpha-Gal A enzyme. Ask your healthcare provider if Galafold is right for you.